Carbiogene Therapeutics Co. Ltd. is a high-tech biomedical innovation enterprise jointly founded by well-known scientists at home and abroad, integrating research and development, production and sales. It is a "5050 plan" enterprise and a national high-tech enterprise introduced by the Zhejiang Government of China. Carbiogene Therapeutics has established an industry pattern with new anti-tumor immunotherapy products (new generation CAR-T, AI CAR-T, CAR-NK) as the leading, retroviral vector technology platform, new DC vaccine, immune cell and stem cell biological resource bank, medical laboratory center and digital medical health platform. The company is committed to promoting the clinical application of a new generation of tumor immune precision therapy technology.

Disease Domain	Count

Neoplasms	6
Immune System Diseases	4
Hemic and Lymphatic Diseases	3
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

CAR-T	6
Autologous CAR-T	1
Cell therapy	1

Top 5 Target	Count

BCMA(B-cell maturation protein)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 25 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

Phase 1

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

CBG002 ( BCMA )	Refractory Multiple Myeloma More	Phase 1
CBG-166	Advanced Hepatocellular Carcinoma More	Phase 1
CBG-131	CLDN18.2 positive Pancreatic Cancer More	Early Phase 1
CBG-139	Acute Myeloid Leukemia More	Preclinical
CBG-318	Multiple Myeloma More	Preclinical

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis